Clinical trials · Pennsylvania
Urothelial Carcinoma Bladder clinical trials in Pennsylvania
We’re tracking 26 recruiting urothelial carcinoma bladder studies with a site in Pennsylvania — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Pennsylvania
- NCT06545955RecruitingPhase 3
Gene therapy study for high-grade bladder cancer not responding to BCG
This trial tests a gene therapy called nadofaragene firadenovec, given directly into the bladder, either alone or with chemo or immunotherapy. It's for people with high-grade bladder cancer that hasn't gone away after BCG treatment.
Lancaster, PennsylvaniaAges 18 years+ - NCT07218380RecruitingPhase 3
Study of Vepugratinib for advanced bladder or urinary tract cancer
This trial tests an experimental drug called Vepugratinib for people with advanced urinary tract cancer that has a specific change in the FGFR3 gene. It may be an option if you haven't had other treatments for advanced cancer and are looking for a new approach.
Lancaster, PennsylvaniaAges 18 years+
Where these studies are running in Pennsylvania
Institutions with a site for the recruiting urothelial carcinoma bladder studies listed above.
- Allegheny General Hospital
- Keystone Urology Specialists
- Lancaster General Hospital - Ann B. Barshinger Cancer Institute
- MidLantic Urology
- University of Pennsylvania - Perelman Center for Advanced Medicine - Penn Urology
- University of Pittsburgh Medical Center - Shadyside Medical Building
What taking part in a urothelial carcinoma bladder study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Urothelial Carcinoma Bladder trials in other states
Common questions
- Are there urothelial carcinoma bladder clinical trials in Pennsylvania?
- Yes. We're currently tracking 26 recruiting urothelial carcinoma bladder studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a urothelial carcinoma bladder study in Pennsylvania?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pennsylvania to take part?
- Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a urothelial carcinoma bladder trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New urothelial carcinoma bladder studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.